88 related articles for article (PubMed ID: 18433795)
1. Cinnamtannin B-1 as an antioxidant and platelet aggregation inhibitor.
López JJ; Jardín I; Salido GM; Rosado JA
Life Sci; 2008 May; 82(19-20):977-82. PubMed ID: 18433795
[TBL] [Abstract][Full Text] [Related]
2. Cinnamtannin B-1 from bay wood reduces abnormal intracellular Ca2+ homeostasis and platelet hyperaggregability in type 2 diabetes mellitus patients.
Bouaziz A; Salido S; Linares-Palomino PJ; Sanchez A; Altarejos J; Bartegi A; Salido GM; Rosado JA
Arch Biochem Biophys; 2007 Jan; 457(2):235-42. PubMed ID: 17118329
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the intracellular mechanisms involved in the antiaggregant properties of cinnamtannin B-1 from bay wood in human platelets.
Ben Amor N; Bouaziz A; Romera-Castillo C; Salido S; Linares-Palomino PJ; Bartegi A; Salido GM; Rosado JA
J Med Chem; 2007 Aug; 50(16):3937-44. PubMed ID: 17602466
[TBL] [Abstract][Full Text] [Related]
4. Cinnamtannin B-1 from bay wood exhibits antiapoptotic effects in human platelets.
Bouaziz A; Romera-Castillo C; Salido S; Linares-Palomino PJ; Altarejos J; Bartegi A; Rosado JA; Salido GM
Apoptosis; 2007 Mar; 12(3):489-98. PubMed ID: 17195094
[TBL] [Abstract][Full Text] [Related]
5. Effect of cinnamtannin B-1 on cholecystokinin-8-evoked responses in mouse pancreatic acinar cells.
Rivera-Barreno R; del Castillo-Vaquero A; Salido GM; Gonzalez A
Clin Exp Pharmacol Physiol; 2010 Oct; 37(10):980-8. PubMed ID: 20626416
[TBL] [Abstract][Full Text] [Related]
6. Antiaggregant effects of Arbutus unedo extracts in human platelets.
El Haouari M; López JJ; Mekhfi H; Rosado JA; Salido GM
J Ethnopharmacol; 2007 Sep; 113(2):325-31. PubMed ID: 17681442
[TBL] [Abstract][Full Text] [Related]
7. Olive tree wood phenolic compounds with human platelet antiaggregant properties.
Zbidi H; Salido S; Altarejos J; Perez-Bonilla M; Bartegi A; Rosado JA; Salido GM
Blood Cells Mol Dis; 2009; 42(3):279-85. PubMed ID: 19195914
[TBL] [Abstract][Full Text] [Related]
8. Cinnamtannin B-1, a natural antioxidant that reduces the effects of H(2)O(2) on CCK-8-evoked responses in mouse pancreatic acinar cells.
Gonzalez A; Santofimia-Castaño P; Rivera-Barreno R; Salido GM
J Physiol Biochem; 2012 Jun; 68(2):181-91. PubMed ID: 22120978
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of the platelet antiaggregant properties of phenolic antioxidants structurally related to rosmarinic acid.
Chapado L; Linares-Palomino PJ; Salido S; Altarejos J; Rosado JA; Salido GM
Bioorg Chem; 2010 Jun; 38(3):108-14. PubMed ID: 20042216
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant and cellular activities of anthocyanins and their corresponding vitisins A--studies in platelets, monocytes, and human endothelial cells.
García-Alonso M; Rimbach G; Rivas-Gonzalo JC; De Pascual-Teresa S
J Agric Food Chem; 2004 Jun; 52(11):3378-84. PubMed ID: 15161201
[TBL] [Abstract][Full Text] [Related]
11. Oligomeric proanthocyanidin complexes: history, structure, and phytopharmaceutical applications.
Fine AM
Altern Med Rev; 2000 Apr; 5(2):144-51. PubMed ID: 10767669
[TBL] [Abstract][Full Text] [Related]
12. Cinnamtannin B-1 regulates cell proliferation of spinal cord astrocytes and protects the cell from oxygen-glucose-serum deprivation/reoxygenation-induced apoptosis.
Chi Z; Ma X; Cui G; Li M; Li F
Int J Mol Sci; 2013 Jul; 14(8):15827-37. PubMed ID: 23903044
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet activity of beta-carboline alkaloids from Perganum harmala: a possible mechanism through inhibiting PLCgamma2 phosphorylation.
Im JH; Jin YR; Lee JJ; Yu JY; Han XH; Im SH; Hong JT; Yoo HS; Pyo MY; Yun YP
Vascul Pharmacol; 2009; 50(5-6):147-52. PubMed ID: 19073282
[TBL] [Abstract][Full Text] [Related]
14. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase.
Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675
[TBL] [Abstract][Full Text] [Related]
15. Platelet function in hypertension.
El Haouari M; Rosado JA
Blood Cells Mol Dis; 2009; 42(1):38-43. PubMed ID: 18829351
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory mechanisms of dihydroginsenoside Rg3 in platelet aggregation: critical roles of ERK2 and cAMP.
Lee WM; Kim SD; Park MH; Cho JY; Park HJ; Seo GS; Rhee MH
J Pharm Pharmacol; 2008 Nov; 60(11):1531-6. PubMed ID: 18957175
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of Terminalia arjuna on platelet activation in vitro in healthy subjects and patients with coronary artery disease.
Malik N; Dhawan V; Bahl A; Kaul D
Platelets; 2009 May; 20(3):183-90. PubMed ID: 19437336
[TBL] [Abstract][Full Text] [Related]
18. Novel P2Y12 adenosine diphosphate receptor antagonists for inhibition of platelet aggregation (I): in vitro effects on platelets.
Bryant J; Post JM; Alexander S; Wang YX; Kent L; Schirm S; Tseng JL; Subramanyam B; Buckman B; Islam I; Yuan S; Sullivan ME; Snider M; Morser J
Thromb Res; 2008; 122(4):523-32. PubMed ID: 18495218
[TBL] [Abstract][Full Text] [Related]
19. Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs).
Yamagishi S; Matsui T; Takenaka K; Nakamura K; Takeuchi M; Inoue H
Diabetes Metab Res Rev; 2009 Mar; 25(3):266-71. PubMed ID: 19165765
[TBL] [Abstract][Full Text] [Related]
20. Feroniellin B, a new highly potent human platelet aggregation inhibitor from Feroniella lucida.
Phuwapraisirisan P; Surapinit S; Jeenapongsa R; Tip-pyang S; Kokpol U
Phytother Res; 2007 May; 21(5):485-7. PubMed ID: 17245685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
